Clinical Trials
Gut Health Connections to Overall Health - Part 2 of a 2-part series
Gut Health Connections to Overall Health (part 2 of 2)
In part 1 of this series, we discussed how gut bacteria, or the microbiota, affect your health, from metabolism to mood, and contribute to a number of chronic diseases.
Gut Health Connections to Overall Health - Part 1 of a 2-part series
“All Disease Begins in The Gut.” – Hippocrates
Research increasingly supports the idea that your gut bacteria are tied to your probability of intestinal disorders and other conditions, like diabetes, obesity, depression, and colon cancer. In this issue of the Altasciences blog, we offer an oversight of the research into how they are linked.
Genetic therapies – part 2 of a 2-part series
In today's blog, we focus on the advances being made in medicine that are affected or influenced by the increased understanding of the human genome.
ISSUE NO. 7 — Understanding the Intrinsic and Extrinsic Factors that Alter Drug Exposure and Toxicity
Up Close and Personal with Ingrid Holmes
Ingrid joined Altasciences in 2011, as Vice President of Clinical Operations at the Montreal site, a facility currently housing seven clinical units with 265 beds, and dedicated
ISSUE NO. 5 — Metabolic Disorders (Obesity, Diabetes, NAFLD/NASH) — Updated 2021
Metabolic disorders are conditions that disrupt normal metabolism and the process of converting food to energy at the cellular level.
Pain – is it all in your head?
Pain is a fascinating phenomenon, acting as a physiological warning system that alerts us of potential dangers in our environment.
ISSUE NO. 4 — Key Considerations for Biosimilar Clinical Pharmacology Studies
Topical and Transdermal – Getting Under Your Skin
The skin is the largest organ of the human body, measuring 22 square feet, on average.
WHAT IT TAKES — Central Nervous System (CNS) Clinical Trials
Biopharmaceutical companies developing new CNS products can face special obstacles.